Escherichia coli K1 is the most common cause of meningitis in neonates. Ineffectiveness of antibiotic therapy over the last few decades and the emergence of antibiotic resistant E. coli strains imply that there is a great unmet need for new methods of treatment and prevention. Incomplete understanding of the mechanisms involved at every step of pathogenesis is attributed to this poor outcome. For example, the mechanisms by which E. coli K1 enters the human brain microvascular endothelial cells (HBMEC) that constitute the BBB and disrupts tight junctions (TJs) are poorly understood. We have established that outer membrane protein A (OmpA) of E. coli interacts with endothelial cell gp96 (Ecgp);a receptor specifically expressed on HBMEC, to invade and disrupt the TJs. The importance of OmpA-Ecgp interaction is further supported by our findings that 1) E. coli strains that either lack OmpA or express non-functional OmpA do not induce meningitis in a newborn mouse or rat model and 2) Mice in which Ecgp expression was suppressed were resistant to E. coli infection. Intriguingly, OmpA interaction with Ecgp triggers the production of nitric oxide (NO) due to iNOS activation and thereby enhances the expression of the receptor to allow the bacteria to invade more efficiently. In agreement, iNOS-/- mice are resistant to E. coli infection and also administration of an iNOS specific inhibitor, aminoguanidine (AG), during high-grade bacteremia prevented the occurrence of meningitis. Novel computer modeling methods were utilized to study the interaction of OmpA and Ecgp and to identify small molecule inhibitors that prevent the E. coli invasion of HBMEC. Three small molecules exhibited more than 80% inhibition of E. coli invasion in HBMEC both in vitro and in vivo. Our studies have also revealed that Ecgp interaction with Robo4 at the HBMEC membrane increases upon infection with E. coli. Further, a GTPase activating protein, IQGAP1, which binds both actin and b-catenin, appears to play a role in the invasion process. IQGAP1 is a client protein for Stat3, which was shown to be associated with Ecgp, indicating that IQGAP1 might be relaying Ecgp mediated signals to induce E. coli invasion. Thus, our hypothesis is that the interaction of OmpA and Ecgp is fundamental to initiate signaling events that induce E. coli invasion and increased permeability of the BBB.
In Aim 1, we propose to define the binding domains of Ecgp that orchestrate the interaction of Ecgp/Robo4 with OmpA. Next, to understand whether Ecgp interaction with Robo4 contributes to signaling events to induce NO production and thereby modulating IQGAP1 association with b-CAT to dislodge it from TJs will be tested in Aim 2. Then, in Aim 3 we will modify the antagonists for higher inhibition efficiency and couple them to nanoparticles, which will carry a load of iNOS inhibitors to deliver to brain to prevent E. coli induced meningitis in newborn rats. Translational medicine is the outcome of this application in which studies of basic biology and applied technology to develop new strategies of prevention will be integrated.

Public Health Relevance

Ineffectiveness of antibiotic therapy over the last few decades and the emergence of multidrug resistant strains make the neonatal meningitis due to E. coli K1 a serious health problem;and imply that there is a great unmet need for new methods of treatment and prevention. Our studies have demonstrated that the interaction of OmpA and endothelial cell gp96 (Ecgp) is fundamental to initiate signaling events that induce E. coli invasion and increased permeability of the blood-brain barrier (BBB). In this application, we will dissect the structural features of Ecgp that promote signaling events necessary for the invasion process and to breach the BBB permeability, which information will be used to develop Ecgp antagonists to couple to nanoparticles for targeted delivery to brain for preventing E. coli meningitis in newborn animals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040567-17
Application #
8291201
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Korpela, Jukka K
Project Start
1997-01-01
Project End
2016-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
17
Fiscal Year
2012
Total Cost
$448,066
Indirect Cost
$130,721
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
052277936
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Shanmuganathan, Muthusamy V; Krishnan, Subramanian; Fu, Xiaowei et al. (2014) Escherichia coli K1 induces pterin production for enhanced expression of Fcýý receptor I to invade RAW 264.7 macrophages. Microbes Infect 16:134-41
Scott, Caitlin E; Abrol, Ravinder; Ahn, Kwang H et al. (2013) Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations. Protein Sci 22:101-13
Emami, Claudia N; Mittal, Rahul; Wang, Larry et al. (2012) Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii. J Surg Res 172:18-28
Krishnan, Subramanian; Fernandez, G Esteban; Sacks, David B et al. (2012) IQGAP1 mediates the disruption of adherens junctions to promote Escherichia coli K1 invasion of brain endothelial cells. Cell Microbiol 14:1415-33
Liu, Yaoping; Mittal, Rahul; Solis, Norma V et al. (2011) Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog 7:e1002305
Mittal, Rahul; Prasadarao, Nemani V (2010) Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion. Cell Microbiol 12:67-83
Mittal, Rahul; Gonzalez-Gomez, Ignacio; Panigrahy, Ashok et al. (2010) IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med 207:1307-19
Singamsetty, Vijay K; Wang, Ying; Shimada, Hiroyuki et al. (2008) Outer membrane protein A expression in Enterobacter sakazakii is required to induce microtubule condensation in human brain microvascular endothelial cells for invasion. Microb Pathog 45:181-91
Hunter, Catherine J; Singamsetty, Vijay K; Chokshi, Nikunj K et al. (2008) Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis 198:586-93
Maruvada, Ravi; Argon, Yair; Prasadarao, Nemani V (2008) Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion. Cell Microbiol 10:2326-38

Showing the most recent 10 out of 18 publications